Mineralys Therapeutics, Inc.
MLYS
25 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | May 14 1:42 AM | David Malcom RodmanChief Medical Officer | Sale | 14,056 | $28.58 | $401.8K | 63,443(D) | View → |
| May 12, 2026 | May 14 1:42 AM | David Malcom RodmanChief Medical Officer | Sale | 6,348 | $29.36 | $186.3K | 69,792(D) | View → |
| May 11, 2026 | May 14 1:42 AM | David Malcom RodmanChief Medical Officer | Sale | 2,171 | $29.71 | $64.5K | 69,792(D) | View → |
| May 13, 2026 | May 13 8:11 PM | Rodman David Malcom | Proposed Sale | 14,056 | $28.58 | $401.8K | — | View → |
| May 12, 2026 | May 12 9:05 PM | Rodman David Malcom | Proposed Sale | 6,348 | $29.36 | $186.3K | — | View → |
| May 11, 2026 | May 11 8:27 PM | Rodman David Malcom | Proposed Sale | 2,171 | $29.71 | $64.5K | — | View → |
| Apr 17, 2026 | Apr 21 10:59 PM | David Malcom RodmanChief Medical Officer | Sale | 416 | $31.33 | $13.0K | 69,792(D) | View → |
| Apr 17, 2026 | Apr 17 8:17 PM | Rodman David Malcom | Proposed Sale | 416 | $31.33 | $13.0K | — | View → |
| Apr 15, 2026 | Apr 16 1:45 AM | David Malcom RodmanChief Medical Officer | Sale | 6,348 | $27.66 | $175.6K | 69,792(D) | View → |
| Apr 13, 2026 | Apr 16 1:45 AM | David Malcom RodmanChief Medical Officer | Sale | 14,058 | $26.54 | $373.1K | 76,140(D) | View → |
| Apr 13, 2026 | Apr 16 1:45 AM | Jon CongletonDirector, Chief Executive Officer | Sale | 15,730 | $26.83 | $422.0K | 689,321(D) | View → |
| Apr 15, 2026 | Apr 15 8:21 PM | Rodman David Malcom | Proposed Sale | 6,348 | $27.66 | $175.6K | — | View → |
| Apr 9, 2026 | Apr 14 1:13 AM | David Malcom RodmanChief Medical Officer | Sale | 2,170 | $27.38 | $59.4K | 76,140(D) | View → |
| Apr 13, 2026 | Apr 13 8:22 PM | Congleton Jon | Proposed Sale | 15,730 | $26.83 | $422.0K | — | View → |
| Apr 13, 2026 | Apr 13 8:18 PM | Rodman David Malcom | Proposed Sale | 14,058 | $26.54 | $373.1K | — | View → |
| Apr 9, 2026 | Apr 9 8:24 PM | Rodman David Malcom | Proposed Sale | 2,170 | $27.38 | $59.4K | — | View → |
| Mar 31, 2026 | Apr 2 10:54 PM | Jon CongletonDirector, Chief Executive Officer | Sale | 75,000 | $26.27 | $2.0M | 705,051(D) | View → |
| Mar 31, 2026 | Apr 2 10:53 PM | Daphne KarydasDirector | Sale | 3,000 | $25.00 | $75.0K | 6,200(D) | View → |
| Mar 31, 2026 | Mar 31 8:18 PM | Karydas Daphne | Proposed Sale | 3,000 | $25.00 | $75.0K | — | View → |
| Mar 31, 2026 | Mar 31 8:15 PM | Congleton Jon | Proposed Sale | 75,000 | $26.27 | $2.0M | — | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Feb 21 12:47 AM | Derek DiroccoDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:46 AM | David Malcom RodmanChief Medical Officer | Grant/Award | 51,300 | $28.06 | 51,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:46 AM | Adam Scott LevyCFO and Secretary | Grant/Award | 53,300 | $28.06 | 53,300(D) | View → |
| Feb 17, 2026 | Feb 17 11:56 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 5,417(D) | View → |
| Feb 13, 2026 | Feb 14 12:25 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,707 | $14.25 | 100,001(D) | View → |
| Feb 12, 2026 | Feb 14 12:25 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,349 | $1.08 | 31,743(D) | View → |
| Feb 9, 2026 | Feb 11 11:58 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,171 | $16.00 | 26,047(D) | View → |
| Jan 20, 2026 | Jan 21 1:33 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 416 | $15.44 | 5,834(D) | View → |
← Previous
Page 2 of 2